The influence of Coronavirus-2019 (COVID-19) on heart transplantation is considerable. Reports of COVID-19 infection in recently transplanted patients are scarce. We present a 60-year-old male patient with COVID-19 infection, diagnosed 6 days after transplantation. His clinical course revealed 2 phases. Initially, there were mild respiratory symptoms for which he was treated with remdesivir and noninvasive respiratory support. In a second phase with clinical deterioration on postoperative day 22, further respiratory decline led to the administration of convalescent plasma, with satisfactory response and further improvement of his condition.
All Keywords
【초록키워드】 COVID-19, convalescent plasma, Infection, Remdesivir, Clinical course, COVID-19 infection, male, Patient, administration, Clinical deterioration, Support, report, patient with COVID-19, diagnosed, treated, postoperative, Initially, mild respiratory symptom, noninvasive respiratory, 【제목키워드】 COVID-19, heart, transplantation,
【초록키워드】 COVID-19, convalescent plasma, Infection, Remdesivir, Clinical course, COVID-19 infection, male, Patient, administration, Clinical deterioration, Support, report, patient with COVID-19, diagnosed, treated, postoperative, Initially, mild respiratory symptom, noninvasive respiratory, 【제목키워드】 COVID-19, heart, transplantation,